+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global ELISpot & FluoroSpot Assay Market by Product (Acessories, Analyzers, Assay Kits), Application (Autoimmune Disorders, Infectious Diseases, Oncology), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5847097
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The ELISpot & FluoroSpot Assay Market grew from USD 292.68 million in 2023 to USD 313.61 million in 2024. It is expected to continue growing at a CAGR of 7.02%, reaching USD 470.74 million by 2030.

FluoroSpot assays can visualize and enumerate the number of polyfunctional T cells and single-cytokine producers. FluoroSpot assay uses fluorescent labels with discrete, non-overlapping wavelengths to differentiate individual cytokines and co-secreted cytokines. Both ELISPOT and fluoroSpot assays are widely used in immuno-monitoring of clinical trials where both quantitative information and T cell phenotype identification at a single cell level are required. The rising increasing prevalence of chronic diseases across the world and a surge in biomedical research have necessitated the deployment of robust immunological assays for diagnosis and monitoring. Furthermore, the rise in investments in the pharmaceutical and biotechnology sectors, driven by a growing focus on personalized medicine, has expanded the application scope of these assays. However, the complexity of operating the assay and the chances of variability in test results impede the widespread adoption of the assays. Additionally, the difficulty of interpretation of test results and data analysis complexities with ELISpot & FluoroSpot assays further pose complications for utilization of ELISpot and FluoroSpot. However, the healthcare industry's continuous push toward innovation coupled with R&D initiatives aimed towards improving the specificity and accuracy of the assays can overcome the technical constraints of using ELISpot and FluoroSpot assay. A growing emphasis on immunotherapy treatments for cancer and other diseases further creates a significant need for ELISpot and FluoroSpot assays.

Regional Insights

The continued growth of ELISpot and FluoroSpot assays in the Americas region can be credited to its well-established healthcare and biotechnological sectors, significant investments in research and development, and the presence of major market players. Particularly, the United States, with a robust healthcare infrastructure and increased healthcare spending, is driving the growth in this region. Europe is another key region for the ELISpot and FluoroSpot assays, with countries such as Germany, the United Kingdom, France, and Italy leading the growth of the technology. The growth in Europe is driven by advanced healthcare systems and the presence of reputed research institutions. Moreover, collaborations between academic institutions and the industry foster innovation in assay development. The European market also benefits from supportive regulatory policies aimed towards the development of advanced ELISpot and FluoroSpot assays. In the APAC region, the need for ELISpot and FluoroSpot assays is expanding due to increased awareness regarding advanced immunodiagnostic techniques, increased awareness about chronic diseases, and government initiatives aimed at enhancing healthcare outcomes. Furthermore, the presence of contract research organizations (CROs) in this region positions the Asia Pacific as a prominent region for the growth of both assays.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the ELISpot & FluoroSpot Assay Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing prevalence of chronic and infectious diseases
  • Rising need for immunotherapy and personalized medicines
  • Growing usage owing to an increase in immune monitoring studies

Market Restraints

  • Complexity and variability of assay protocols

Market Opportunities

  • Advancements in the development of user-friendly and high-throughput assay systems
  • High potential of eLISpot & fluoroSpot assay in veterinary applications

Market Challenges

  • Interpretation and data analysis complexities with eLISpot & fluoroSpot assays

Market Segmentation Analysis

  • Product: Growing preference for comprehensive assay kits among research institutions and laboratories
  • Application: Expanding government initiatives to propel oncology research, diagnosis, and therapy
  • End-user: Pertaining use of ELISpot & FluoroSpot assays in research and clinical practices providing unprecedented accuracy and reliable results

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the ELISpot & FluoroSpot Assay Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the ELISpot & FluoroSpot Assay Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Singamaneni to develop advanced protein imaging method

McKelvey School of Engineering at Washington University in St. Louis received a grant of USD 450,000 from the National Science Foundation to develop a method called Plasmon-Enhanced Expansion FluoroSpot (PEEFS) to address the difficulty of discerning individual cell behaviors and differences. PEEFS combines a very bright fluorescent nanoparticle with expansion microscopy to image secreted proteins with high sensitivity and precision and accurately measure minute cell differences.

Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing

Celerion, a contract research organization (CRO), enhanced its molecular and cellular capabilities to adhere to Good Laboratory Practice and Good Clinical Practice (GLP/GCP) standards. This expansion encompasses various advanced techniques, including ELISpot & FluoroSpot Assay, flow cytometry, and qPCR analyses. These additions enable Celerion to provide comprehensive and high-quality services to its clients in the biopharmaceutical sector.

PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection

PerkinElmer's Oxford Immunotec has obtained FDA approval for its T-Cell Select reagent kit, which allows certified laboratories to automate the workflow of the T-SPOT.TB test. The T-Cell Select reagent material facilitates the positive selection of peripheral blood mononuclear cells (PBMCs) through magnetic bead-based cell separation. This approved kit streamlines the preparation of cells for the T-SPOT.TB test, an ELISPOT Interferon-Gamma Release Assays (IGRA) that detects latent TB infection, thereby ensuring compliance with global regulations.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the ELISpot & FluoroSpot Assay Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the ELISpot & FluoroSpot Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Anogen-Yes Biotech Laboratories Ltd, Autoimmun Diagnostika GmbH, Becton, Dickinson and Company, Bio-Techne Corporation, BIOSYS Scientific Devices GmbH, BOC Sciences, Broughton Life Sciences Limited, CellCarta Biosciences Inc., Creative Proteomics, Elabscience, Full Moon BioSystems, Inc., Jackson ImmunoResearch Inc., Mabtech AB, Merck KGaA, Oxford Immunotec USA, Inc., Oy Medix Biochemica Ab, ProImmune Ltd., Quansys Biosciences Inc., SBH Sciences, U-CyTech BV, and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the ELISpot & FluoroSpot Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Acessories
  • Analyzers
  • Assay Kits

Application

  • Autoimmune Disorders
  • Infectious Diseases
  • Oncology
  • Organ Transplantation
  • Vaccine Development

End-User

  • Academic Research Institutes
  • Hospitals & Clinical Laboratories

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic and infectious diseases
5.1.1.2. Rising need for immunotherapy and personalized medicines
5.1.1.3. Growing usage owing to an increase in immune monitoring studies
5.1.2. Restraints
5.1.2.1. Complexity and variability of assay protocols
5.1.3. Opportunities
5.1.3.1. Advancements in the development of user-friendly and high-throughput assay systems
5.1.3.2. High potential of eLISpot & fluoroSpot assay in veterinary applications
5.1.4. Challenges
5.1.4.1. Interpretation and data analysis complexities with eLISpot & fluoroSpot assays
5.2. Market Segmentation Analysis
5.2.1. Product: Growing preference for comprehensive assay kits among research institutions and laboratories
5.2.2. Application: Expanding government initiatives to propel oncology research, diagnosis, and therapy
5.2.3. End-user: Pertaining use of ELISpot & FluoroSpot assays in research and clinical practices providing unprecedented accuracy and reliable results
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. ELISpot & FluoroSpot Assay Market, by Product
6.1. Introduction
6.2. Acessories
6.3. Analyzers
6.4. Assay Kits
7. ELISpot & FluoroSpot Assay Market, by Application
7.1. Introduction
7.2. Autoimmune Disorders
7.3. Infectious Diseases
7.4. Oncology
7.5. Organ Transplantation
7.6. Vaccine Development
8. ELISpot & FluoroSpot Assay Market, by End-User
8.1. Introduction
8.2. Academic Research Institutes
8.3. Hospitals & Clinical Laboratories
9. Americas ELISpot & FluoroSpot Assay Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific ELISpot & FluoroSpot Assay Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa ELISpot & FluoroSpot Assay Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Singamaneni to develop advanced protein imaging method
12.3.2. Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing
12.3.3. PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. ELISPOT & FLUOROSPOT ASSAY MARKET RESEARCH PROCESS
FIGURE 2. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ELISPOT & FLUOROSPOT ASSAY MARKET DYNAMICS
FIGURE 7. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ELISPOT & FLUOROSPOT ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACESSORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACESSORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 161. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 287. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 288. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abcam PLC
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Anogen-Yes Biotech Laboratories Ltd
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BIOSYS Scientific Devices GmbH
  • BOC Sciences
  • Broughton Life Sciences Limited
  • CellCarta Biosciences Inc.
  • Creative Proteomics
  • Elabscience
  • Full Moon BioSystems, Inc.
  • Jackson ImmunoResearch Inc.
  • Mabtech AB
  • Merck KGaA
  • Oxford Immunotec USA, Inc.
  • Oy Medix Biochemica Ab
  • ProImmune Ltd.
  • Quansys Biosciences Inc.
  • SBH Sciences
  • U-CyTech BV
  • ZenBio, Inc.

Methodology

Loading
LOADING...

Table Information